Inaugural Breast Cancer Symposium Awards 18,000 Dollars To Oncology Fellows, USA

Main Category: Breast Cancer
Also Included In: Cancer / Oncology
Article Date: 08 Sep 2007 - 1:00 PST

email to a friend   printer friendly   view / write opinions   rate article

The co-sponsoring organizations of the 2007 Breast Cancer Symposium announced the winners of the Symposium Merit Awards. Eighteen physicians-in-training will receive funding to assist with their travel to attend the Symposium, to be held September 7-8 in San Francisco.

"We are pleased to honor these physicians at the inaugural Breast Cancer Symposium for their high-level performance in clinical research," said Gabriel N. Hortobagyi, MD, FACP, chair of the Symposium Steering Committee, Immediate Past President of ASCO, and chair of the Department of Breast Medical Oncology at the University of Texas M.D. Anderson Cancer Center. "Fellowship training programs continue to have a positive impact on patient care, and these young leaders have set the bar for future award recipients in the advancement of breast cancer research and treatment."

This year's awardees are the first group of physicians to receive ASCO's Merit Awards in breast cancer and represent institutions from across the globe. Awardees were selected based on the scientific merit of their abstracts and will present their studies at the Symposium.

The Breast Cancer Symposium will bring together surgical, medical and radiation oncologists to discuss new research and to help physicians apply new genetic and molecular discoveries to the care of people with breast cancer. The meeting is designed to foster intimate, interactive discussion of new findings and critical issues in breast cancer prevention, diagnosis and management.

Co-sponsors include the American Society of Breast Disease, the American Society of Breast Surgeons, the American Society of Clinical Oncology, the American Society for Therapeutic Radiology and Oncology, National Consortium of Breast Centers and the Society of Surgical Oncology.

2007 Breast Cancer Symposium Merit Award Recipients

Robin Scott Akins, MD
University of Miami Miller School of Medicine
Metaplastic breast cancer: University of Miami experience.

Shaheenah S. Dawood, MD
The University of Texas M.D. Anderson Cancer Center
Prognosis of women with breast cancer and CNS metastases by HER2 status.

Regina M. Fearmonti, MD
The University of Texas M.D. Anderson Cancer Center
Margin width correlates with residual disease at re-excision for ductal carcinoma in situ (DCIS) of the breast.

Christopher Friese, PhD, RN
Dana-Farber Cancer Institute
Breast biopsy patterns and outcomes in SEER-Medicare data.

Carlos A. Garcia-Etienne, MD
European Institute of Oncology
When sentinel lymph node is intramammary.

Norah L. Henry, MD, PhD
University of Michigan Medical Center
Aromatase inhibitor (AI)-induced musculoskeletal toxicity in a prospective clinical trial: a Consortium on Breast Cancer Pharmacogenomics (COBRA) study.

Nina J. Karlin, MD, FACP
Olive View - UCLA Medical Center
An association between thyroid disease and breast cancer.

Marie C. Lee, MD
University of Michigan Comprehensive Cancer Center
Increased frequency estrogen receptor (ER) negative and aneuploid breast cancer in African-American women at all stages of disease: first analysis from the National Cancer Data Base (NCDB).

Aye Moe Thu Ma, MD
The University of Texas Southwestern Medical Center at Dallas
Comparison of cell yield and cytology for nipple duct lavage and random periareolar fine needle aspiration biopsies performed in the same patients.

Ravi A. Madan, MD
National Institute of Health - National Cancer Institute
PANVAC (V) based vaccine therapy for patients (pts) with metastatic breast cancer (mBC).

Kelly W. Mitchell, MD
The University of North Carolina
Reporting of race and ethnicity in breast cancer research.

Elizabeth A. Mittendorf, MD
The University of Texas M.D. Anderson Cancer Center
Lymphovascular invasion and lobular histology are strong predictors of detecting isolated tumor cells in sentinel lymph nodes from early stage breast cancer patients.

Dimitry S. Nuyten, MD
The Netherlands Cancer Institute
Revealing targeted therapy for human cancer by gene module maps.

Chia C. Portera, MD, PhD
National Cancer Institute
Identification of gene expression profiles of inflammatory breast cancer using whole genome DNA microarray analysis.

Jennifer R. Reed, MD
Anne Arundel Medical Center
Assessing the utility of magnetic resonance imaging for surgical planning of DCIS breast cancer patients.

Mangesh A. Thorat, MD, MBBS
Indiana University School of Medicine
Characterization of Estrogen Receptor Positive breast cancers: Gene expression analysis of archived tumors.

Jennifer F. Waljee, MD, MPH
University of Michigan
Predictors of re-excision among women undergoing breast conserving surgery for breast cancer.

Jiping Wang, MD, PhD
University at Buffalo, The State University of New York
Log odds of positive lymph nodes in the prognosis of node positive breast cancer.

The 2007 Merit Awards are funded through The ASCO Foundation and are supported by an educational grant from Abraxis Oncology; Amgen Oncology; Aptium Oncology; AstraZeneca; Bayer Pharmaceuticals Corporation; Bristol-Myers Squibb and ImClone Systems Incorporated; Celegene Corporation; Novartis Oncology; Onyx Pharmaceuticals, Inc.; OSI Oncology; Ovation Pharmaceuticals, Inc. and sanofi-aventis U.S.

http://www.asco.org